5

Cian Healthcare

542678 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has reduced debt.
  • Promoter holding has increased by 67.9% over last quarter.

Weaknesses

6
  • Stock is trading at 4.53 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -17.4% over past five years.
  • Company has a low return on equity of -18.6% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 163 days.

Growth Rate

Revenue Growth
-8% higher than 3Y
Net Income Growth
27%

Quarterly Results

Particulars Sep 2019Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Mar 2026
Sales
29
28
39
35
47
31
38
31
33
62
19
12
17
Expenses
26
23
34
28
44
30
32
24
28
51
20
17
20
Operating Profit
3
4
5
7
3
1
5
7
4
11
-1
-5
-3
OPM %
10%
15%
13%
20%
7%
2.9%
14%
22%
14%
18%
-8%
-44%
-18%
Other Income
0
1
0
0
0
0
1
0
0
0
-12
0
-13
Interest
4
4
4
4
3
3
3
3
3
6
2
1
0
Depreciation
2
3
2
1
2
2
3
3
3
5
2
2
2
PBT
-2
-2
-1
2
-2
-4
0
2
-1
0
-18
-8
-18
Tax %
0%
17%
23%
28%
7%
-13%
-167%
14%
37%
-400%
0%
0%
0%
Net Profit
-2
-2
-1
1
-2
-4
0
2
-1
0
-18
-8
-18
EPS in Rs
-0.86
-0.75
-0.46
0.48
-0.72
-1.54
0.19
0.62
-0.59
0.1
-7.3
-3.09
-7.19
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
57
74
78
69
62
31
28
Expenses
50
62
74
56
51
37
35
Operating Profit
7
12
4
13
11
-7
-7
OPM %
13%
16%
6%
19%
18%
-21%
-24%
Other Income
1
0
0
1
0
-12
-12
Interest
7
8
7
6
6
3
0
Depreciation
4
3
4
5
5
4
4
PBT
-4
1
-6
2
0
-26
-23
Tax %
7%
91%
-8%
-2%
-1600%
0%
0%
Net Profit
-4
0
-6
2
1
-26
-23
EPS in Rs
-1.62
0.02
-2.21
0.81
0.34
-10.39
-9.32
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
23
23
25
25
25
25
25
Reserves
35
35
30
32
33
7
-16
Borrowings
73
71
63
61
56
55
29
Other Liabilities
25
28
47
42
47
69
24
Total Liabilities
157
157
166
160
161
156
62
Fixed Assets
39
37
50
45
39
35
32
CWIP
25
26
13
14
15
15
6
Investments
5
5
5
5
5
5
0
Other Assets
87
90
98
97
102
101
23
Total Assets
157
157
166
160
161
156
62
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-7
6
9
5
12
21
21
Investing
-27
3
1
3
-1
0
13
Financing
36
-10
-11
-7
-10
-4
-50
Net Cash Flow
1
-1
-1
0
0
17
-17
Free Cash Flow
-26
4
4
4
11
20
29
CFO/OP
-99
49
197
37
106
-315
-296
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
128
94
125
140
121
206
163
Inventory Days
214
277
300
400
486
420
82
Days Payable
176
186
270
296
371
671
219
Cash Conversion Cycle
166
185
155
244
236
-45
26
Working Capital Days
15
16
38
41
26
-729
-96
ROCE %
—
7%
0%
7%
5%
-11%
-16%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Cian Healthcare insights

61 extracted metrics + investor summaries across FY16–FY26.

Log in — free

Shareholding Pattern

Promot.95.00%Public5.00%As ofMar 2026

Documents

Frequently Asked Questions about Cian Healthcare

What does Cian Healthcare Ltd do?
Cian Healthcare Ltd is a BSE-SME listed pharmaceutical-formulations manufacturer with own /franchise brands, third-party manufacturing, institutional/government supply and exports. It makes tablets, capsules, soft-gels, liquid orals, ointments/creams, sachets and cosmetics across gynaecology, h...
Where is Cian Healthcare Ltd (542678) listed?
Cian Healthcare Ltd trades under code 542678 on the BSE.
Which sector does Cian Healthcare Ltd belong to?
Cian Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Cian Healthcare Ltd is a BSE-SME listed pharmaceutical-formulations manufacturer with own /franchise brands, third-party manufacturing, institutional/government supply and exports. It makes tablets, capsules, soft-gels, liquid orals, ointments/creams, sachets and cosmetics across gynaecology, haematinic, cardio-diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins and nutrients. The company exited CIRP under new promoter control in FY26[1]

Website cian.co
Listed 2019-05-23
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542678.md for Cian Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List